Is the Use of Autologous Platelet-Rich Plasma Gels in Gynecologic, Cardiac, and General, Reconstructive Surgery Beneficial?

Author(s): Peter A.M. Everts, Maarten M. Hoogbergen, Tjaarda A.Weber, Roger J.J. Devilee, Gust van Monftort, Ignace H.J.T. de Hingh

Journal Name: Current Pharmaceutical Biotechnology

Volume 13 , Issue 7 , 2012

Become EABM
Become Reviewer

Abstract:

Tissue repair at wound sites begins with clot formation, and subsequently platelet degranulation with the release of platelet growth factors, which are necessary and well-regulated processes to achieve wound healing. Plateletderived growth factors are biologically active substances that enhance tissue repair mechanisms, such as chemotaxis, cell proliferation, angiogenesis, extracellular matrix deposition, and remodeling. This review describes the biological background and results on the topical use of autologous platelet-rich plasma and platelet gel in gynecologic, cardiac, and general surgical procedures, including chronic wound management and soft-tissue injuries.

Keywords: Platelets, platelet-rich plasma (PRP), platelet gel (PG), growth factors, wound healing, cardiac surgery, gynecology, general surgery, adipose graft.

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 13
ISSUE: 7
Year: 2012
Published on: 05 May, 2012
Page: [1163 - 1172]
Pages: 10
DOI: 10.2174/138920112800624346
Price: $65

Article Metrics

PDF: 13